Back to discover
Disease
Convalescence
Clinical development underwayEmerging research
2
Publications
3
Clinical trials
2022
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
Research2022-01-31Nature
Persistence of Ebola Virus in Ocular Fluid during Convalescence.
Research2015-05-07The New England journal of medicine
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
3
0
0
3
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20152022
Most influential
Major themes1
- Immunity, Cellular1
Leading journals2
- Nature1
- The New England journal of medicine1
Leading researchers8
- Adriaanse M1
- Aremu O1
- Baguma R1
- Bekker LG1
- Benede N1
- Bernstein M1
- Bhiman JN1
- Bodenstein A1
Affiliations (unnormalised)6
- Africa Health Research Institute1
- and the Department of Pathology and Laboratory Medicine (C.S.K.)1
- Cape Heart Institute1
- Center for Infectious Disease and Vaccine Research1
- Centre for Epidemic Response and Innovation1
- Centre for the AIDS Programme of Research in South Africa1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
The period of recovery following an illness.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.